| 发明名称 | Treatment of vascular complications of diabetes | ||
| 摘要 | A peptide consisting of 7-17 amino acids and including the adjacent hexamer TX1EX2X3E, where X1, X2 and X3 can be any natural or non natural amino acid, wherein the peptide does not exhibit TNF-receptor-binding activity and is cyclic, for the treatment or prevention of vascular complications in diabetes patients. | ||
| 申请公布号 | US9359419(B2) | 申请公布日期 | 2016.06.07 |
| 申请号 | US201013805839 | 申请日期 | 2010.10.20 |
| 申请人 | Apeptico Forschung UND Entwicklung GMBH | 发明人 | Fischer Bernhard;Lucas Rudolf |
| 分类号 | A61K38/12;C07K7/64;A61K38/08;C07K14/525 | 主分类号 | A61K38/12 |
| 代理机构 | Chalker Flores, LLP | 代理人 | Singleton Chainey P.;Flores Edwin S.;Chalker Flores, LLP |
| 主权项 | 1. A method for the treatment of vascular complications, except retinopathy, in diabetes patients comprising the step of: administering to a diabetes patient, said diabetes patient being at risk of developing vascular complications, except retinopathy, or having vascular complications, except retinopathy, an amount of a peptide consisting of 7-17 amino acids and including the hexamer TX1EX2X3E, wherein X1, X2 and X3 can be any natural or non natural amino acid, wherein the peptide does not exhibit TNF-receptor-binding activity and is cyclic, for treatment of vascular complications, except retinopathy, in said patient. | ||
| 地址 | Vienna AT | ||